A detailed history of Black Rock Inc. transactions in Precigen, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,247,058 shares of PGEN stock, worth $9.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,247,058
Previous 10,363,128 1.12%
Holding current value
$9.22 Million
Previous $15 Million 7.75%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.27 - $1.75 $147,408 - $203,122
-116,070 Reduced 1.12%
10,247,058 $16.2 Million
Q1 2024

May 10, 2024

SELL
$1.21 - $1.75 $915,960 - $1.32 Million
-756,992 Reduced 6.81%
10,363,128 $15 Million
Q4 2023

Feb 13, 2024

BUY
$0.89 - $1.41 $590,837 - $936,045
663,862 Added 6.35%
11,120,120 $14.9 Million
Q3 2023

Nov 13, 2023

BUY
$1.08 - $1.85 $96,783 - $165,785
89,614 Added 0.86%
10,456,258 $14.8 Million
Q2 2023

Aug 11, 2023

BUY
$0.96 - $1.4 $753,369 - $1.1 Million
784,760 Added 8.19%
10,366,644 $11.9 Million
Q1 2023

May 12, 2023

BUY
$0.88 - $2.19 $1.24 Million - $3.09 Million
1,409,360 Added 17.25%
9,581,884 $10.2 Million
Q4 2022

Feb 13, 2023

BUY
$1.27 - $2.26 $427,958 - $761,563
336,975 Added 4.3%
8,172,524 $12.4 Million
Q3 2022

Nov 14, 2022

BUY
$1.41 - $2.79 $137,212 - $271,506
97,314 Added 1.26%
7,835,549 $16.6 Million
Q2 2022

Aug 12, 2022

BUY
$1.15 - $2.53 $589,483 - $1.3 Million
512,594 Added 7.09%
7,738,235 $10.4 Million
Q1 2022

May 12, 2022

BUY
$1.91 - $3.98 $88,234 - $183,860
46,196 Added 0.64%
7,225,641 $15.2 Million
Q4 2021

Feb 10, 2022

BUY
$3.53 - $5.5 $25,183 - $39,237
7,134 Added 0.1%
7,179,445 $26.6 Million
Q3 2021

Nov 09, 2021

SELL
$4.99 - $6.55 $117,908 - $154,769
-23,629 Reduced 0.33%
7,172,311 $35.8 Million
Q2 2021

Aug 11, 2021

BUY
$6.24 - $8.22 $44.9 Million - $59.2 Million
7,195,940 New
7,195,940 $46.9 Million

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $187M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.